Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in Belgium, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Belgium data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €417.3k | €467.2k | €517.2k | |||
| Patients | 285 | 319 | 353 |
Forecasts to 2030 — sales, patients and the full Belgium series — are in the Belgium data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
From International Cannabis Weekly, our free global briefing.
Newsweed · №438 · 20 Feb 2026 · Hemp & CBD
№405 · 20 Jun 2025 · Hemp & CBD
Euronews · №403 · 6 Jun 2025 · Regulation
Cannabis Industrie · №398 · 2 May 2025 · Regulation
№339 · 1 Mar 2024 · Regulation
№334 · 26 Jan 2024 · Regulation
In Belgium, the medical use of pure CBD in magistral preparations is legal, all other forms of medical cannabis are not permitted.
Though CBD was never considered illegal in the country, it existed in a legal grey area until 2019, when its distinction from THC and its legal position as a non-narcotic was clarified.
Currently, general practitioners and specialists can prescribe CBD treatment to patients at their discretion.
Magistral CBD products are available as an oil or capsule, prepared by a magistral pharmacist from pure CBD in API form.